These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 8335172)
1. Transfer of type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID). Petersen JS; Marshall MO; Baekkeskov S; Hejnaes KR; Høier-Madsen M; Dyrberg T Diabetologia; 1993 Jun; 36(6):510-5. PubMed ID: 8335172 [TBL] [Abstract][Full Text] [Related]
2. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Richter W; Endl J; Eiermann TH; Brandt M; Kientsch-Engel R; Thivolet C; Jungfer H; Scherbaum WA Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8467-71. PubMed ID: 1382289 [TBL] [Abstract][Full Text] [Related]
3. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression. Jaeger C; Hering BJ; Hatziagelaki E; Federlin K; Bretzel RG J Mol Med (Berl); 1999 Jan; 77(1):45-8. PubMed ID: 9930926 [TBL] [Abstract][Full Text] [Related]
5. The heterogeneity of whole islet cell cytoplasmic antibodies evidenced by absorption test with glutamic acid decarboxylase. Takino H; Kawasaki E; Yano M; Matsumoto K; Uotani S; Okuno S; Takao Y; Yamasaki H; Yamaguchi Y; Akazawa S J Autoimmun; 1994 Jun; 7(3):389-98. PubMed ID: 7916910 [TBL] [Abstract][Full Text] [Related]
6. Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction. Dotta F; Eisenbarth GS Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S85-95. PubMed ID: 2642771 [TBL] [Abstract][Full Text] [Related]
7. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals. Thivolet CH; Tappaz M; Durand A; Petersen J; Stefanutti A; Chatelain P; Vialettes B; Scherbaum W; Orgiazzi J Diabetologia; 1992 Jun; 35(6):570-6. PubMed ID: 1612231 [TBL] [Abstract][Full Text] [Related]
8. Contribution of glutamate decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies. Marshall MO; Høyer PE; Petersen JS; Hejnaes KR; Genovese S; Dyrberg T; Bottazzo GF J Autoimmun; 1994 Aug; 7(4):497-508. PubMed ID: 7980851 [TBL] [Abstract][Full Text] [Related]
9. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Roll U; Christie MR; Füchtenbusch M; Payton MA; Hawkes CJ; Ziegler AG Diabetes; 1996 Jul; 45(7):967-73. PubMed ID: 8666150 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies. Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036 [TBL] [Abstract][Full Text] [Related]
11. Low prevalence of islet autoimmunity in adult diabetes and low predictive value of islet autoantibodies in the general adult population of northern Italy. Bosi EP; Garancini MP; Poggiali F; Bonifacio E; Gallus G Diabetologia; 1999 Jul; 42(7):840-4. PubMed ID: 10440126 [TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus. Yoon JW; Jun HS Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511 [TBL] [Abstract][Full Text] [Related]
13. Human autoantibodies react with glutamic acid decarboxylase antigen in human and rat but not in mouse pancreatic islets. Velloso LA; Kämpe O; Eizirik DL; Hallberg A; Andersson A; Karlsson FA Diabetologia; 1993 Jan; 36(1):39-46. PubMed ID: 8436251 [TBL] [Abstract][Full Text] [Related]
14. Autoantibodies against a novel 51 kDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I. Velloso LA; Winqvist O; Gustafsson J; Kämpe O; Karlsson FA Diabetologia; 1994 Jan; 37(1):61-9. PubMed ID: 8150232 [TBL] [Abstract][Full Text] [Related]
15. Elimination of islet cell antibodies and glutamic acid decarboxylase antibodies II in a patient with newly diagnosed insulin-dependent diabetes mellitus. Richter WO; Donner MG; Schwandt P J Clin Apher; 1997; 12(4):196-9. PubMed ID: 9483183 [TBL] [Abstract][Full Text] [Related]
16. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice. Rohane PW; Shimada A; Kim DT; Edwards CT; Charlton B; Shultz LD; Fathman CG Diabetes; 1995 May; 44(5):550-4. PubMed ID: 7729614 [TBL] [Abstract][Full Text] [Related]
17. Islet autoantibodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15 years of age. Lindberg B; Ivarsson SA; Landin-Olsson M; Sundkvist G; Svanberg L; Lernmark A Diabetologia; 1999 Feb; 42(2):181-7. PubMed ID: 10064098 [TBL] [Abstract][Full Text] [Related]
19. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study. Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480 [TBL] [Abstract][Full Text] [Related]
20. Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies. Richter W; Eiermann TH; Endl J; Seissler J; Wolfahrt S; Brandt M; Jungfer H; Scherbaum WA Diabetologia; 1993 Aug; 36(8):785-90. PubMed ID: 7691667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]